<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
<front>
<journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id><journal-id journal-id-type="pmc">ploscomp</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Computational Biology</journal-title></journal-title-group><issn pub-type="ppub">1553-734X</issn><issn pub-type="epub">1553-7358</issn><publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="publisher-id">09-PLCB-RA-0800R2</article-id><article-id pub-id-type="doi">10.1371/journal.pcbi.1000539</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cardiovascular Disorders</subject><subject>Cardiovascular Disorders/Coronary Artery Disease</subject><subject>Cardiovascular Disorders/Myocardial Infarction</subject><subject>Cardiovascular Disorders/Vascular Biology</subject><subject>Mathematics</subject><subject>Public Health and Epidemiology/Environmental Health</subject><subject>Public Health and Epidemiology/Epidemiology</subject><subject>Public Health and Epidemiology/Occupational and Industrial Medicine</subject></subj-group></article-categories><title-group><article-title>A Model of Cardiovascular Disease Giving a Plausible Mechanism for the Effect of Fractionated Low-Dose Ionizing Radiation Exposure</article-title><alt-title alt-title-type="running-head">Model for Cardiovascular Disease</alt-title></title-group><contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Little</surname><given-names>Mark P.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gola</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tzoulaki</surname><given-names>Ioanna</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
</contrib-group><aff id="aff1">          <addr-line>Department of Epidemiology and Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom</addr-line>       </aff><contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Richardson</surname><given-names>Richard B.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group><aff id="edit1">McMaster University, Canada</aff><author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">mark.little@imperial.ac.uk</email></corresp>
<fn fn-type="con"><p>Conceived and designed the experiments: MPL. Performed the experiments: MPL. Analyzed the data: MPL AG IT. Wrote the paper: MPL AG IT.</p></fn>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><month>10</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>23</day><month>10</month><year>2009</year></pub-date><volume>5</volume><issue>10</issue><elocation-id>e1000539</elocation-id><history>
<date date-type="received"><day>7</day><month>7</month><year>2009</year></date>
<date date-type="accepted"><day>21</day><month>9</month><year>2009</year></date>
</history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2009</copyright-year><copyright-holder>Little et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
<p>Atherosclerosis is the main cause of coronary heart disease and stroke, the two major causes of death in developed society. There is emerging evidence of excess risk of cardiovascular disease at low radiation doses in various occupationally exposed groups receiving small daily radiation doses. Assuming that they are causal, the mechanisms for effects of chronic fractionated radiation exposures on cardiovascular disease are unclear. We outline a spatial reaction-diffusion model for atherosclerosis and perform stability analysis, based wherever possible on human data. We show that a predicted consequence of multiple small radiation doses is to cause mean chemo-attractant (MCP-1) concentration to increase linearly with cumulative dose. The main driver for the increase in MCP-1 is monocyte death, and consequent reduction in MCP-1 degradation. The radiation-induced risks predicted by the model are quantitatively consistent with those observed in a number of occupationally-exposed groups. The changes in equilibrium MCP-1 concentrations with low density lipoprotein cholesterol concentration are also consistent with experimental and epidemiologic data. This proposed mechanism would be experimentally testable. If true, it also has substantive implications for radiological protection, which at present does not take cardiovascular disease into account. The Japanese A-bomb survivor data implies that cardiovascular disease and cancer mortality contribute similarly to radiogenic risk. The major uncertainty in assessing the low-dose risk of cardiovascular disease is the shape of the dose response relationship, which is unclear in the Japanese data. The analysis of the present paper suggests that linear extrapolation would be appropriate for this endpoint.</p>
</abstract><abstract abstract-type="summary"><title>Author Summary</title>
<p>Atherosclerosis is the main cause of coronary heart disease and stroke, the two major causes of death in developed society. There is emerging evidence of excess risk of cardiovascular disease in various occupationally exposed groups, exposed to fractionated radiation doses with small doses/fraction. The mechanisms for such effects of fractionated low-dose radiation exposures on cardiovascular disease are unclear. We outline a spatial reaction-diffusion model for early stage atherosclerotic lesion formation and perform a stability analysis, based on experimentally derived parameters. We show that following multiple small radiation doses the chemo-attractant (MCP-1) concentration increases proportionally to cumulative dose; this is driven by radiation-induced monocyte death. This will result in risk of atherosclerosis increasing approximately linearly with cumulative dose. This proposed mechanism would be testable. If true, it also has substantive implications for radiological protection, which at present does not take cardiovascular disease into account. The major uncertainty in assessing low-dose risk of cardiovascular disease is the shape of the dose response relationship, which is unclear in high dose data. Our analysis suggests that linear extrapolation would be appropriate.</p>
</abstract><funding-group><funding-statement>The project was funded in part by the European Commission under contract FP6-036465 (NOTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="11"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Atherosclerosis is the main cause of coronary heart disease and stroke, the two major causes of death in developed society <xref ref-type="bibr" rid="pcbi.1000539-Murray1">[1]</xref>. Though previously initiation of atherosclerosis was attributed mainly to lipid accumulation within the arterial walls, it is now widely accepted that inflammation plays a vital role in the initiation and progression of the disease <xref ref-type="bibr" rid="pcbi.1000539-Ross1">[2]</xref>–<xref ref-type="bibr" rid="pcbi.1000539-Hansson1">[5]</xref>.</p>
<p>For some time cardiovascular effects of high dose radiotherapy (RT) have been known <xref ref-type="bibr" rid="pcbi.1000539-Adams1">[6]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-McGale1">[7]</xref>. A variety of effects are observed, presumed to result from inactivation of large numbers of cells and associated functional impairment of the affected tissue. Among such effects are direct damage to the structures of the heart – including marked diffuse fibrotic damage, especially of the pericardium and myocardium, pericardial adhesions, microvascular damage and stenosis of the valves − and to the coronary arteries; these sorts of damage occur both in patients receiving RT and in experimental animals <xref ref-type="bibr" rid="pcbi.1000539-Adams1">[6]</xref>. There is emerging evidence of excess risk of cardiovascular disease at much lower radiation doses and occurring a long time after radiation exposure in the Japanese atomic bomb survivor Life Span Study (LSS) cohort <xref ref-type="bibr" rid="pcbi.1000539-Preston1">[8]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-Yamada1">[9]</xref> and in various occupationally-exposed groups <xref ref-type="bibr" rid="pcbi.1000539-Howe1">[10]</xref>–<xref ref-type="bibr" rid="pcbi.1000539-Azizova1">[14]</xref> although not in all (e.g., <xref ref-type="bibr" rid="pcbi.1000539-Vrijheid1">[15]</xref>). Assuming that they are causal, the likely mechanisms for such effects of low dose and/or chronic radiation exposures on cardiovascular disease are not clear <xref ref-type="bibr" rid="pcbi.1000539-Little1">[16]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-Little2">[17]</xref>. It is of interest that elevated levels of the pro-inflammatory cytokines IL-6, CRP, TNF-α and INF-γ, but also increased levels of the (generally) anti-inflammatory cytokine IL-10, have been observed in the Japanese atomic bomb survivors <xref ref-type="bibr" rid="pcbi.1000539-Hayashi1">[18]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-Hayashi2">[19]</xref>. There was also dose-related elevation in erythrocyte sedimentation rate and in levels of IgG, IgA and total immunoglobulins in this cohort, all markers of systemic inflammation <xref ref-type="bibr" rid="pcbi.1000539-Hayashi2">[19]</xref>.</p>
<p>In this paper we outline a mathematical formulation of a model of cardiovascular disease that is largely based on the inflammatory hypothesis articulated by Ross <xref ref-type="bibr" rid="pcbi.1000539-Ross1">[2]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-Ross2">[3]</xref>. The motivation behind the mathematical modelling is to encompass various factors contributing to the inflammatory process and subsequently to atherosclerotic formation. As atherosclerosis is not only a multifactorial, but also a multi-step disease, we concentrate on modelling chronic inflammation, primarily at early stages in the disease, but outlining a treatment for the later stages that lead to plaque rupture. The model is to some extent based on a model of McKay <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-McKay1">[20]</xref>, although there are significant departures from and elaborations of this model. In particular, features are borrowed from the generally rather simpler models of Cobbold <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Cobbold1">[21]</xref> and Ibragimov <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Ibragimov1">[22]</xref>. Stability analysis of a simplified version of the model will be performed. We shall be particularly concerned with mechanisms for effects of cholesterol and fractionated low dose radiation exposure in this inflammation model, and outline a case for radiation-induced monocyte cell death as a candidate pathway.</p>
</sec><sec id="s2">
<title>Models</title>
<sec id="s2a">
<title>Spatial atherosclerosis model</title>
<p>In this section we shall consider a spatial atherosclerosis model based on a simplification of the biology outlined in <xref ref-type="supplementary-material" rid="pcbi.1000539.s001">Text S1</xref> section A.1. The model is entirely concerned with processes in the intima (the tissue immediately adjacent to the endothelial cell lining of the arteries), <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e001" xlink:type="simple"/></inline-formula>, where the disease process is thought to be initiated, with boundary conditions determined in part by species concentrations in the lumen, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e002" xlink:type="simple"/></inline-formula>. Specifically, the model is concerned with atherosclerosis in the large arteries, for example the coronary, carotid and other cerebral arteries, lesions in which account for the largest part of cardiovascular morbidity and mortality <xref ref-type="bibr" rid="pcbi.1000539-Lusis1">[4]</xref>. In <xref ref-type="supplementary-material" rid="pcbi.1000539.s001">Text S1</xref> section A.2 we outline a rather fuller version of this spatial model, incorporating more of the biological detail of section A.1 of <xref ref-type="supplementary-material" rid="pcbi.1000539.s001">Text S1</xref>. The main point of the section is the stability analysis that we perform in the final part, this being the reason for the simplifications. The processes are a combination of stage 2 and stage 3 processes outlined in section A.1 of <xref ref-type="supplementary-material" rid="pcbi.1000539.s001">Text S1</xref>. The set of reaction-diffusion equations is as follows:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e003" xlink:type="simple"/><label>(1)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e004" xlink:type="simple"/><label>(2)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e005" xlink:type="simple"/><label>(3)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e006" xlink:type="simple"/><label>(4)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e007" xlink:type="simple"/><label>(5)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e008" xlink:type="simple"/><label>(6)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e009" xlink:type="simple"/><label>(7)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e010" xlink:type="simple"/><label>(8)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e011" xlink:type="simple"/><label>(9)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e012" xlink:type="simple"/></inline-formula> are the undamaged and damaged EC concentrations, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e013" xlink:type="simple"/></inline-formula> is the chemo-attractant (monocyte chemo-attractant protein 1 (MCP-1)) concentration, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e014" xlink:type="simple"/></inline-formula> is the proliferation factor (macrophage colony-stimulating factor (M-CSF)), <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e015" xlink:type="simple"/></inline-formula> is the monocyte concentration, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e016" xlink:type="simple"/></inline-formula> is the macrophage concentration, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e017" xlink:type="simple"/></inline-formula> is the bound lipid concentration and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e018" xlink:type="simple"/></inline-formula> is the necrotic core concentration. <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e019" xlink:type="simple"/></inline-formula> is the LDL concentration with oxidation state <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e020" xlink:type="simple"/></inline-formula> (the number of vitamin E molecules unoxidized - 1) (so <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e021" xlink:type="simple"/></inline-formula> is the LDL with all vitamin E oxidized, although itself unoxidised and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e022" xlink:type="simple"/></inline-formula> is the fully oxidised LDL concentration). <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e023" xlink:type="simple"/></inline-formula> are the chemotactic factors (assumed constant) associated with monocytes, macrophages and T-lymphocytes, respectively; the mechanism for chemotaxis (as given by the terms involving these coefficients) is similar to that of Keller and Segel <xref ref-type="bibr" rid="pcbi.1000539-Keller1">[23]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-Keller2">[24]</xref>. <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e024" xlink:type="simple"/></inline-formula> are the rates of diffusion of the associated species. MCP-1 (also known as CCL2) is known to recruit monocytes, T-lymphocytes and dendritic cells to sites of tissue injury. <xref ref-type="supplementary-material" rid="pcbi.1000539.s002">Table S1</xref> gives further details of candidate molecules for some of the model variables.</p>
<p>While many of the components of these equations are standard (further details are given in <xref ref-type="supplementary-material" rid="pcbi.1000539.s001">Text S1</xref> section A), a few deserve further explanation. In equation (3) we assume that chemo-attractant is degraded (via the term <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e025" xlink:type="simple"/></inline-formula>) at a rate proportional to the concentration of macrophages, T-cells and monocytes; McKay <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-McKay1">[20]</xref> do not assume such degradation. We assume this because chemo-attractant molecules are assumed to adhere to cell-surface markers on these cell species (the mechanism by which they are assumed to attract); a similar assumption was made by Ibragimov <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Ibragimov1">[22]</xref>. In equation (7) we assume that the bound lipid concentration, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e026" xlink:type="simple"/></inline-formula>, is increased (internalised within macrophages) at a rate determined by the concentration of macrophages, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e027" xlink:type="simple"/></inline-formula>, and the concentration of fully oxidized LDL, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e028" xlink:type="simple"/></inline-formula> (the <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e029" xlink:type="simple"/></inline-formula> term in equation (7)), but that this bound lipid is released when the macrophages die (the <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e030" xlink:type="simple"/></inline-formula> term in equation (7)), a function of macrophage concentration and bound lipid concentration, as given in McKay <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-McKay1">[20]</xref>. As discussed in <xref ref-type="supplementary-material" rid="pcbi.1000539.s001">Text S1</xref> section A (equations (A.23)–(A.24) and preceding), we shall assume that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e031" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e032" xlink:type="simple"/></inline-formula>. The macrophage flux, as per equation (6), is given by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e033" xlink:type="simple"/></inline-formula>. Therefore the bound lipid flux (all carried by macrophage diffusion and chemotaxis) is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e034" xlink:type="simple"/></inline-formula>. This leads to a chemotaxis term <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e035" xlink:type="simple"/></inline-formula> similar to that assumed by McKay <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-McKay1">[20]</xref>. We obtain a diffusion term that is entirely due to macrophage diffusion, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e036" xlink:type="simple"/></inline-formula>, in contrast with McKay <italic>et al.</italic> who assume a standard diffusion term in the lipid, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e037" xlink:type="simple"/></inline-formula>; we fail to see how bound lipid can diffuse apart from macrophages - by definition it is bound within macrophages. [<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e038" xlink:type="simple"/></inline-formula> is the divergence (div) operator, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e039" xlink:type="simple"/></inline-formula> is the gradient (grad) operator and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e040" xlink:type="simple"/></inline-formula> is the Laplacean operator.] Further details are given in <xref ref-type="supplementary-material" rid="pcbi.1000539.s001">Text S1</xref> section A.</p>
</sec><sec id="s2b">
<title>Boundary conditions</title>
<p>Let <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e041" xlink:type="simple"/></inline-formula> be the outward unit normal on the boundary (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e042" xlink:type="simple"/></inline-formula>), where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e043" xlink:type="simple"/></inline-formula> is the boundary between intima and lumen, and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e044" xlink:type="simple"/></inline-formula> is the boundary between intima and media. Then we have:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e045" xlink:type="simple"/><label>(10)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e046" xlink:type="simple"/><label>(11)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e047" xlink:type="simple"/><label>(12)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e048" xlink:type="simple"/><label>(13)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e049" xlink:type="simple"/><label>(14)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e050" xlink:type="simple"/><label>(15)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e051" xlink:type="simple"/><label>(16)</label></disp-formula>[<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e052" xlink:type="simple"/></inline-formula> are the monocyte and T-lymphocyte concentrations on the immediate lumenal side of the EC layer.] These boundary conditions are similar to those assumed by Ibragimov <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Ibragimov1">[22]</xref>. Note that in (12) and (15) we convert from the monocyte and T-lymphocyte flux (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e053" xlink:type="simple"/></inline-formula> respectively) to the rate of change of concentration per unit distance (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e054" xlink:type="simple"/></inline-formula> respectively) via the inverse of the respective diffusion constants. We assume the following parametric form of the boundary monocyte and T-lymphocyte flux in (12) and (15):<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e055" xlink:type="simple"/><label>(17)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e056" xlink:type="simple"/><label>(18)</label></disp-formula>The fundamentally linear form of these is inspired by data in Takaku <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Takaku1">[25]</xref> and Klouche <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Klouche1">[26]</xref>. The threshold levels of chemo-attractant, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e057" xlink:type="simple"/></inline-formula>, below which these fluxes are zero, is inspired by similar assumptions made by Ibragimov <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Ibragimov1">[22]</xref>; as we discuss below, non-zero threshold levels are needed for there to be a stable solution.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Equilibrium solution</title>
<p>We assume that the system is in spatial and temporal equilibrium at some time <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e058" xlink:type="simple"/></inline-formula>, and is subject to some perturbation after that point. Let <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e059" xlink:type="simple"/></inline-formula> be the equilibrium values of the various quantities, and let <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e060" xlink:type="simple"/></inline-formula> be the differences from these equilibrium values after perturbation – so that, for example, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e061" xlink:type="simple"/></inline-formula>, and similarly for the other species. Therefore, for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e062" xlink:type="simple"/></inline-formula> to be the equilibrium values we have by (1)–(9):<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e063" xlink:type="simple"/><label>(19)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e064" xlink:type="simple"/><label>(20)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e065" xlink:type="simple"/><label>(21)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e066" xlink:type="simple"/><label>(22)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e067" xlink:type="simple"/><label>(23)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e068" xlink:type="simple"/><label>(24)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e069" xlink:type="simple"/><label>(25)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e070" xlink:type="simple"/><label>(26)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e071" xlink:type="simple"/><label>(27)</label></disp-formula>In order that the system be in equilibrium, the boundary monocyte and T-lymphocyte flux must be zero, so we must have that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e072" xlink:type="simple"/></inline-formula>; for the remainder of this section we therefore assume this. Assuming the coefficients are non-trivial (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e073" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e074" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e075" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e076" xlink:type="simple"/></inline-formula>) these simplify to (19) and (20) and:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e077" xlink:type="simple"/><label>(28)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e078" xlink:type="simple"/><label>(29)</label></disp-formula>Putting together (19), (20) and (29) we see that:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e079" xlink:type="simple"/><label>(30)</label></disp-formula>This implies a non-linear relationship between LDL <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e080" xlink:type="simple"/></inline-formula> and the equilibrium chemo-attractant level <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e081" xlink:type="simple"/></inline-formula>. However, as is clear from <xref ref-type="fig" rid="pcbi-1000539-g001">Figures 1</xref>–<xref ref-type="fig" rid="pcbi-1000539-g002">2</xref>, only for very high levels of LDL, multiples in excess of 50 of the baseline levels (see <xref ref-type="supplementary-material" rid="pcbi.1000539.s004">Table S3</xref>), are there appreciable departures from linearity.</p>
<fig id="pcbi-1000539-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000539.g001</object-id><label>Figure 1</label><caption>
<title>MCP-1 concentration <italic>vs</italic> baseline LDL (small).</title>
<p>Equilibrium chemo-attractant (MCP-1) concentration, <italic>C<sub>eq</sub></italic>, as a function of small multiples of baseline LDL level (<xref ref-type="supplementary-material" rid="pcbi.1000539.s004">Table S3</xref>), using parameters given in <xref ref-type="supplementary-material" rid="pcbi.1000539.s003">Tables S2</xref>, <xref ref-type="supplementary-material" rid="pcbi.1000539.s004">S3</xref>.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.g001" xlink:type="simple"/></fig><fig id="pcbi-1000539-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000539.g002</object-id><label>Figure 2</label><caption>
<title>MCP-1 concentration <italic>vs</italic> baseline LDL (large).</title>
<p>Equilibrium chemo-attractant (MCP-1) concentration, <italic>C<sub>eq</sub></italic>, as a function of large multiples of baseline LDL level (<xref ref-type="supplementary-material" rid="pcbi.1000539.s004">Table S3</xref>), using parameters given in <xref ref-type="supplementary-material" rid="pcbi.1000539.s003">Tables S2</xref>, <xref ref-type="supplementary-material" rid="pcbi.1000539.s004">S3</xref>.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.g002" xlink:type="simple"/></fig>
<p>We shall often assume that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e082" xlink:type="simple"/></inline-formula>. In all that follows we assume a limiting process, so that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e083" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e084" xlink:type="simple"/></inline-formula>. If we perform the obvious linearisations in equations (1)–(9) and ignore all second and higher order terms in <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e085" xlink:type="simple"/></inline-formula> we obtain:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e086" xlink:type="simple"/><label>(31)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e087" xlink:type="simple"/><label>(32)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e088" xlink:type="simple"/><label>(33)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e089" xlink:type="simple"/><label>(34)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e090" xlink:type="simple"/><label>(35)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e091" xlink:type="simple"/><label>(36)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e092" xlink:type="simple"/><label>(37)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e093" xlink:type="simple"/><label>(38)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e094" xlink:type="simple"/><label>(39)</label></disp-formula>The boundary conditions (10)–(16), together with (17), (18) translate to:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e095" xlink:type="simple"/><label>(40)</label></disp-formula>Green's first identity (for general scalar <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e096" xlink:type="simple"/></inline-formula> functions <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e097" xlink:type="simple"/></inline-formula> and domain <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e098" xlink:type="simple"/></inline-formula>) states that:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e099" xlink:type="simple"/><label>(41)</label></disp-formula>Integrating (33)–(39) over the intima, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e100" xlink:type="simple"/></inline-formula>, we have by (41) that:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e101" xlink:type="simple"/><label>(42)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e102" xlink:type="simple"/><label>(43)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e103" xlink:type="simple"/><label>(44)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e104" xlink:type="simple"/><label>(45)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e105" xlink:type="simple"/><label>(46)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e106" xlink:type="simple"/><label>(47)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e107" xlink:type="simple"/><label>(48)</label></disp-formula>In <xref ref-type="supplementary-material" rid="pcbi.1000539.s001">Text S1</xref> section B we outline solutions to (31)–(32), (42)–(48) in various cases. As shown there, if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e108" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e109" xlink:type="simple"/></inline-formula> then:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e110" xlink:type="simple"/><label>(49)</label></disp-formula>From <xref ref-type="supplementary-material" rid="pcbi.1000539.s003">Table S2</xref> it is clear that these conditions are likely to be always satisfied: <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e111" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e112" xlink:type="simple"/></inline-formula>. If <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e113" xlink:type="simple"/></inline-formula> then using the results of <xref ref-type="supplementary-material" rid="pcbi.1000539.s001">Text S1</xref> section B ((B.11)–(B.16)):<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e114" xlink:type="simple"/><label>(50)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e115" xlink:type="simple"/><label>(51)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e116" xlink:type="simple"/><label>(52)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e117" xlink:type="simple"/><label>(53)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e118" xlink:type="simple"/><label>(54)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e119" xlink:type="simple"/><label>(55)</label></disp-formula>for some <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e120" xlink:type="simple"/></inline-formula>, so that in general <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e121" xlink:type="simple"/></inline-formula> do not decay to 0 as <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e122" xlink:type="simple"/></inline-formula>, although by (B.18) <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e123" xlink:type="simple"/></inline-formula> does (at least in <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e124" xlink:type="simple"/></inline-formula>). Note in particular that unless <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e125" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e126" xlink:type="simple"/></inline-formula>, or possibly (more likely) that<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e127" xlink:type="simple"/></inline-formula>, then there will be time trends in the averaged quantities for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e128" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e129" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e130" xlink:type="simple"/></inline-formula>, so that in particular stability cannot be re-attained.</p>
<p>In <xref ref-type="fig" rid="pcbi-1000539-g003">Figures 3</xref>–<xref ref-type="fig" rid="pcbi-1000539-g004"/><xref ref-type="fig" rid="pcbi-1000539-g005"/><xref ref-type="fig" rid="pcbi-1000539-g006"/><xref ref-type="fig" rid="pcbi-1000539-g007">7</xref> we plot the variation of the spatially-averaged chemo-attractant, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e131" xlink:type="simple"/></inline-formula>, derived assuming a non-zero equilibrium concentration of monocytes (<xref ref-type="supplementary-material" rid="pcbi.1000539.s004">Table S3</xref>) and using (B.1b’). The perturbation is assumed to take place via killing of monocytes in the intima, which in this case could be produced by ionizing radiation, and also via damage to endothelial cells, produced in the same way. We do not assume instantaneous changes in any of the other species, i.e., <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e132" xlink:type="simple"/></inline-formula>. The reason for this is that by (28) <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e133" xlink:type="simple"/></inline-formula> (assuming as we do that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e134" xlink:type="simple"/></inline-formula>), so that radiation would not have any species to act on in equilibrium. For the parameters used here (given in <xref ref-type="supplementary-material" rid="pcbi.1000539.s003">Tables S2</xref> and <xref ref-type="supplementary-material" rid="pcbi.1000539.s004">S3</xref>), the overwhelming contribution is via monocyte killing: by 80 seconds the contribution from this term is 4.5×10<sup>−17</sup> M ml<sup>−1</sup> compared with a contribution of −1.6×10<sup>−18</sup> M ml<sup>−1</sup> via damage to endothelial cells. As can be seen, the change in chemo-attractant concentration occurs (for monocytes and in aggregate) relatively quickly, over a timescale of minutes, although the endothelial cell killing component varies more slowly, over a timescale of hours; after 24 hours this and all other averaged quantities are virtually constant. In contrast to the above general case, when only the monocyte population (of all the species) is perturbed, for a sufficiently long time after exposure (days or more) we have by (50), (52) that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e135" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e136" xlink:type="simple"/></inline-formula>, and by (51), (53), (54) the averaged change in all other species tends to zero. In this case we see that:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e137" xlink:type="simple"/><label>(56)</label></disp-formula>approximated to first order, so that by (30), at least in average, equilibrium can be re-established at these new values of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e138" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e139" xlink:type="simple"/></inline-formula>. We conjecture that in fact equilibrium is re-established for all quantities in this case. It is easy to see that if there were to be further small perturbations in <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e140" xlink:type="simple"/></inline-formula>, at intervals of days or more, the resulting changes in the spatially-averaged quantities would be approximately additive in the corresponding increments, as shown in <xref ref-type="fig" rid="pcbi-1000539-g007">Figure 7</xref>. Moreover, from (50) the excess chemo-attractant (MCP-1) in relation to the monocyte perturbation is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e141" xlink:type="simple"/></inline-formula>. Therefore, so long as the individual monocyte perturbations are small and temporally separated (by a day or more), the increment in chemo-attractant will not depend on anything other than the cumulative absorbed dose, as indicated in <xref ref-type="fig" rid="pcbi-1000539-g007">Figure 7</xref>.</p>
<fig id="pcbi-1000539-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000539.g003</object-id><label>Figure 3</label><caption>
<title>MCP-1 variation over 0–80 seconds after 10 mGy (monocyte, total).</title>
<p>Spatial average (over intima) of increment in chemo-attractant (MCP-1) concentration after 10 mGy of acutely delivered radiation, using parameters given in <xref ref-type="supplementary-material" rid="pcbi.1000539.s003">Tables S2</xref>, <xref ref-type="supplementary-material" rid="pcbi.1000539.s004">S3</xref>. The components of changes in chemo-attractant (MCP-1) level due to monocyte cell killing and total (monocyte+endothelial) cell killing 0–80 seconds after 10 mGy are shown.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.g003" xlink:type="simple"/></fig><fig id="pcbi-1000539-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000539.g004</object-id><label>Figure 4</label><caption>
<title>MCP-1 variation over 0–80 seconds after 10 mGy (endothelial).</title>
<p>Spatial average (over intima) of increment in chemo-attractant (MCP-1) concentration after 10 mGy of acutely delivered radiation, using parameters given in <xref ref-type="supplementary-material" rid="pcbi.1000539.s003">Tables S2</xref>, <xref ref-type="supplementary-material" rid="pcbi.1000539.s004">S3</xref>. The component of changes in chemo-attractant (MCP-1) level due to endothelial cell killing 0–80 seconds after 10 mGy are shown.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.g004" xlink:type="simple"/></fig><fig id="pcbi-1000539-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000539.g005</object-id><label>Figure 5</label><caption>
<title>MCP-1 variation over 0–0.5 hours after 10 mGy (monocyte, total).</title>
<p>Spatial average (over intima) of increment in chemo-attractant (MCP-1) concentration after 10 mGy of acutely delivered radiation, using parameters given in <xref ref-type="supplementary-material" rid="pcbi.1000539.s003">Tables S2</xref>, <xref ref-type="supplementary-material" rid="pcbi.1000539.s004">S3</xref>. The components of changes in chemo-attractant (MCP-1) level due to monocyte cell killing and total (monocyte+endothelial) cell killing 0–0.5 hours after 10 mGy are shown.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.g005" xlink:type="simple"/></fig><fig id="pcbi-1000539-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000539.g006</object-id><label>Figure 6</label><caption>
<title>MCP-1 variation over 0–0.5 hours after 10 mGy (endothelial).</title>
<p>Spatial average (over intima) of increment in chemo-attractant (MCP-1) concentration after 10 mGy of acutely delivered radiation, using parameters given in <xref ref-type="supplementary-material" rid="pcbi.1000539.s003">Tables S2</xref>, <xref ref-type="supplementary-material" rid="pcbi.1000539.s004">S3</xref>. The component of changes in chemo-attractant (MCP-1) level due to endothelial cell killing 0–0.5 hours after 10 mGy are shown.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.g006" xlink:type="simple"/></fig><fig id="pcbi-1000539-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000539.g007</object-id><label>Figure 7</label><caption>
<title>MCP-1 variation over time after 10 mGy/day.</title>
<p>As for <xref ref-type="fig" rid="pcbi-1000539-g003">Figures 3</xref>–<xref ref-type="fig" rid="pcbi-1000539-g004"/><xref ref-type="fig" rid="pcbi-1000539-g005"/><xref ref-type="fig" rid="pcbi-1000539-g006">6</xref>, but assuming fractionated multiple radiation doses, 10 mGy/day.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.g007" xlink:type="simple"/></fig>
<p>In <xref ref-type="fig" rid="pcbi-1000539-g008">Figure 8</xref> we plot the percent proportion of the population whose cumulative chemo-attractant (MCP-1) concentration exceeds the threshold <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e142" xlink:type="simple"/></inline-formula>; as we discuss below, this threshold is the critical point for system stability, exceedance of which makes development of cardiovascular disease much more likely. [The probability is derived assuming that the population distribution MCP-1 is Gaussian with mean and standard deviation (SD) determined by the adult female data of Cannon <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Cannon1">[27]</xref>; the mean is augmented by the radiation-induced increment, given by (B.1b’).] For a range of threshold values between 0.25 and 1.00 times the SD in excess of the mean, we have baseline risks of exceeding the threshold (i.e., cardiovascular disease) of 16–40%. Most developed countries have cumulative cardiovascular disease mortality in the range 20–40% and the world mean is 30% <xref ref-type="bibr" rid="pcbi.1000539-World1">[28]</xref>, so that this range of values of the MCP-1 threshold, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e143" xlink:type="simple"/></inline-formula>, is plausible. For this range of threshold values, <xref ref-type="fig" rid="pcbi-1000539-g008">Figure 8</xref> demonstrates that risks vary remarkably linearly with dose over the dose interval 0–4 Gy. As for <xref ref-type="fig" rid="pcbi-1000539-g007">Figure 7</xref>, the risk will not depend on anything other than the cumulative absorbed dose, as long as this is given in small daily increments.</p>
<fig id="pcbi-1000539-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000539.g008</object-id><label>Figure 8</label><caption>
<title>Risk of MCP-1 exceeding threshold level <italic>vs</italic> dose.</title>
<p>Cumulative risk of exceeding of chemo-attractant (MCP-1) threshold (≈cumulative risk of cardiovascular disease) min[<italic>C<sub>Tm</sub></italic>,C<italic><sub>TT</sub></italic>], as function of radiation dose and threshold value (mean+multiple of population SD <xref ref-type="bibr" rid="pcbi.1000539-Cannon1">[27]</xref> (see <xref ref-type="supplementary-material" rid="pcbi.1000539.s004">Table S3</xref>)).</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.g008" xlink:type="simple"/></fig></sec></sec><sec id="s4">
<title>Discussion</title>
<p>We have outlined a model for early stage atherosclerotic lesion formation, and performed a stability analysis for a simplified version of the model. While some components of the system (in particular the T-lymphocyte concentration, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e144" xlink:type="simple"/></inline-formula>) are stable, in the sense that after perturbations of the system the species concentrations return to their equilibrium value, various other species, in particular the proliferation factor concentration, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e145" xlink:type="simple"/></inline-formula>, the chemo-attractant concentration, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e146" xlink:type="simple"/></inline-formula>, the monocyte concentration, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e147" xlink:type="simple"/></inline-formula>, and the necrotic core, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e148" xlink:type="simple"/></inline-formula>, are generally not stable. In particular, the mean level of chemo-attractant increases continuously and rapidly after instantaneous perturbation by a radiation dose, over a timescale of minutes. However, as we note below, because of cellular repair processes, which are not taken into account in our model, there are reasons for assuming that perturbation by radiation would not be instantaneous, so that this process might be extended over at least a period of hours after exposure. The main driver for the increase in chemo-attractant is the death of monocytes and the consequent reduction in monocyte-induced degradation in chemo-attractant concentration, the <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e149" xlink:type="simple"/></inline-formula> term in (3). It is well known that radiation can cause cell death <xref ref-type="bibr" rid="pcbi.1000539-United1">[29]</xref>, and the degree of cell killing and damage that we assume is consistent with radio-biological expectation <xref ref-type="bibr" rid="pcbi.1000539-Gordon1">[30]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-Deschavanne1">[31]</xref>. Although the change in chemo-attractant (MCP-1) concentration that we assume after 10 mGy is relatively modest, 4.5×10<sup>−17</sup> M ml<sup>−1</sup>, a fractionated dose of 1 Gy would result in 4.5×10<sup>−15</sup> M ml<sup>−1</sup>, comparable with the normal concentration of MCP-1 in adult plasma, 7.9×10<sup>−15</sup> M ml<sup>−1</sup> <xref ref-type="bibr" rid="pcbi.1000539-Cannon1">[27]</xref>. The fact that the range of excess relative risks predicted by our model, 0.49–0.93 Gy<sup>−1</sup>, is consistent with those in a number of occupational studies (<xref ref-type="table" rid="pcbi-1000539-t001">Table 1</xref>) adds to the plausibility of this mechanism.</p>
<table-wrap id="pcbi-1000539-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000539.t001</object-id><label>Table 1</label><caption>
<title>Risks in various human cohorts, and predicted by model. </title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pcbi-1000539-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.t001" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Data</td>
<td align="left" colspan="1" rowspan="1">Reference</td>
<td align="left" colspan="1" rowspan="1">Endpoint (mortality unless otherwise indicated)</td>
<td align="left" colspan="1" rowspan="1">Excess relative risk at 1 Gy (and 95% CI)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Japanese atomic bomb survivors</td>
<td align="left" colspan="1" rowspan="1">Preston <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Preston1">[8]</xref></td>
<td align="left" colspan="1" rowspan="1">Heart disease, 1968–1997 (ICD9 390–429)</td>
<td align="left" colspan="1" rowspan="1">0.17 (0.08, 0.26)<xref ref-type="table-fn" rid="nt102">a</xref><xref ref-type="table-fn" rid="nt103">b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Stroke, 1968–1997 (ICD9 430–438)</td>
<td align="left" colspan="1" rowspan="1">0.12 (0.02, 0.22)<xref ref-type="table-fn" rid="nt102">a</xref><xref ref-type="table-fn" rid="nt103">b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mayak workers</td>
<td align="left" colspan="1" rowspan="1">Azizova and Muirhead <xref ref-type="bibr" rid="pcbi.1000539-Azizova1">[14]</xref></td>
<td align="left" colspan="1" rowspan="1">Ischaemic heart disease morbidity (ICD9 410–414)</td>
<td align="left" colspan="1" rowspan="1">0.109 (0.049, 0.168)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Cerebrovascular disease morbidity (ICD9 430–438)</td>
<td align="left" colspan="1" rowspan="1">0.464 (0.360, 0.567)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chernobyl emergency workers</td>
<td align="left" colspan="1" rowspan="1">Ivanov <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Ivanov1">[11]</xref></td>
<td align="left" colspan="1" rowspan="1">Cerebrovascular disease (ICD10 I60–I69)</td>
<td align="left" colspan="1" rowspan="1">0.45 (0.11, 0.80)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">All circulatory disease (ICD10 I00–I99)</td>
<td align="left" colspan="1" rowspan="1">0.18 (−0.03, 0.39)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">German uranium miner study</td>
<td align="left" colspan="1" rowspan="1">Kreuzer <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Kreuzer1">[56]</xref></td>
<td align="left" colspan="1" rowspan="1">All circulatory disease (ICD10 I00–I99)</td>
<td align="left" colspan="1" rowspan="1">−0.26 (−0.6, 0.05)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Heart disease (ICD10 I00–I52)</td>
<td align="left" colspan="1" rowspan="1">−0.35 (−0.7, 0.009)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Cerebrovascular disease (ICD10 I60–I69)</td>
<td align="left" colspan="1" rowspan="1">0.09 (−0.6, 0.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BNFL workers</td>
<td align="left" colspan="1" rowspan="1">McGeoghegan <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-McGeoghegan1">[12]</xref></td>
<td align="left" colspan="1" rowspan="1">Ischaemic heart disease (ICD9 410–414)</td>
<td align="left" colspan="1" rowspan="1">0.70 (0.37, 1.07)<xref ref-type="table-fn" rid="nt102">a</xref><xref ref-type="table-fn" rid="nt103">b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Cerebrovascular disease (ICD9 430–438)</td>
<td align="left" colspan="1" rowspan="1">0.66 (0.17, 1.27)<xref ref-type="table-fn" rid="nt102">a</xref><xref ref-type="table-fn" rid="nt103">b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">All circulatory disease (ICD9 390–459)</td>
<td align="left" colspan="1" rowspan="1">0.54 (0.30, 0.82)<xref ref-type="table-fn" rid="nt102">a</xref><xref ref-type="table-fn" rid="nt103">b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">UK National Registry for Radiation Workers</td>
<td align="left" colspan="1" rowspan="1">Muirhead <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Muirhead1">[13]</xref></td>
<td align="left" colspan="1" rowspan="1">All circulatory disease (ICD9 390–459)</td>
<td align="left" colspan="1" rowspan="1">0.251 (−0.01, 0.54)<xref ref-type="table-fn" rid="nt103">b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">US Oak Ridge workers</td>
<td align="left" colspan="1" rowspan="1">Richardson and Wing <xref ref-type="bibr" rid="pcbi.1000539-Richardson4">[57]</xref></td>
<td align="left" colspan="1" rowspan="1">Ischaemic heart disease (ICD8 410–414)</td>
<td align="left" colspan="1" rowspan="1">−2.86 (−6.90, 1.18)<xref ref-type="table-fn" rid="nt103">b</xref><xref ref-type="table-fn" rid="nt104">c</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">IARC 15- country nuclear worker study</td>
<td align="left" colspan="1" rowspan="1">Vrijheid <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Vrijheid1">[15]</xref></td>
<td align="left" colspan="1" rowspan="1">Circulatory disease (ICD10 I00–I99, J60–J69, O88.2, R00–R02, R57)</td>
<td align="left" colspan="1" rowspan="1">0.09 (−0.43, 0.70)<xref ref-type="table-fn" rid="nt103">b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Cerebrovascular disease (ICD10 O88.2)</td>
<td align="left" colspan="1" rowspan="1">0.88 (−0.67, 3.16)<xref ref-type="table-fn" rid="nt103">b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Predicted by model, based on chemo-attractant (MCP-1) concentration</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">0.58<xref ref-type="table-fn" rid="nt105">d</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">0.49–0.93<xref ref-type="table-fn" rid="nt106">e</xref></td>
</tr>
</tbody>
</table></alternatives><table-wrap-foot><fn id="nt101"><p>Excess relative risks (per Gy) of cardiovascular disease in the Japanese atomic bomb survivors and in various occupationally exposed groups, compared with excess relative chemo-attractant (MCP-1) concentration at 1 Gy predicted by model.</p></fn><fn id="nt102"><label>a</label><p>90% CI.</p></fn><fn id="nt103"><label>b</label><p>Excess relative risk Sv<sup>−1</sup>.</p></fn><fn id="nt104"><label>c</label><p>Assuming 10 year lag.</p></fn><fn id="nt105"><label>d</label><p>1 Gy assumed given as 100 daily doses of 10 mGy, ERR evaluated by dividing excess MCP-1 concentration by baseline level from data of Cannon <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Cannon1">[27]</xref>.</p></fn><fn id="nt106"><label>e</label><p>ERR at 1 Gy of cumulative risk of exceeding threshold (≈cumulative cardiovascular risk), as given by <xref ref-type="fig" rid="pcbi-1000539-g008">Figure 8</xref>, for levels of MCP-1 threshold min[<italic>C<sub>Tm</sub></italic>,C<italic><sub>TT</sub></italic>] in the range [mean+0.25 SD, mean+1.00 SD], mean and SD taken from data of Cannon <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Cannon1">[27]</xref>.</p></fn></table-wrap-foot></table-wrap>
<p>We have also shown that the model predicts that equilibrium level of chemo-attractant (MCP-1) increases more or less directly with levels of LDL, and in particular oxidized LDL, with slight non-linearity at very high levels of MCP-1. This is in accordance with experimental <xref ref-type="bibr" rid="pcbi.1000539-Cushing1">[32]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-Shi1">[33]</xref> and epidemiological observations <xref ref-type="bibr" rid="pcbi.1000539-Kowalski1">[34]</xref>. Specifically, there is experimental evidence that addition of minimally-oxidised LDL results in a ≈22-fold increase in levels of MCP-1 in ECs in an <italic>in vitro</italic> co-culture system <xref ref-type="bibr" rid="pcbi.1000539-Cushing1">[32]</xref>. In a group of baboons fed a high cholesterol, high fat diet, oxLDL in serum increased by about 19.6% (95% −28.9, 68.1) after 7 weeks, resulting in an increase in serum MCP-1 at that point of 66.7% (95% 54.2, 79.1) <xref ref-type="bibr" rid="pcbi.1000539-Shi1">[33]</xref>. Both of these are consistent with the linear relationship (without constant term) predicted by our model (30).</p>
<p>If radiation dose were to be given in a fractionated manner, with doses separated by a period of hours or more, the model predicts that chemo-attractant (e.g., MCP-1) would increase linearly with cumulative accumulated dose, with a corresponding decrease in the intimal monocyte concentration, as shown in <xref ref-type="fig" rid="pcbi-1000539-g007">Figure 7</xref>. This would carry on until the chemo-attractant concentration at the boundary, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e150" xlink:type="simple"/></inline-formula>, exceeds one or other of the thresholds <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e151" xlink:type="simple"/></inline-formula>, beyond which point an equilibrium solution is no longer possible. At these points, there would be increased trans-intimal flux of monocytes and T-lymphocytes from the lumen, which would result (via (48)) in a continuous increase in necrotic lesion size, and therefore risk of atherosclerosis. The doses used here are moderate (10 mGy/day), such as might occur in occupational exposure settings, and would account for the observed radiation-associated excess risk that has been seen in various groups of nuclear workers <xref ref-type="bibr" rid="pcbi.1000539-Howe1">[10]</xref>–<xref ref-type="bibr" rid="pcbi.1000539-Azizova1">[14]</xref>. The model implies that at least until the chemo-attractant threshold <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e152" xlink:type="simple"/></inline-formula> is exceeded the system is stable, assuming that the conjecture we make after (56) is valid.</p>
<p>If the chemo-attractant threshold <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e153" xlink:type="simple"/></inline-formula> is exceeded as a result of the perturbation term, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e154" xlink:type="simple"/></inline-formula>, resulting in monocyte or T-lymphocyte flux across the EC layer, then extra terms need adding to the right hand side of (44) and (47),<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e155" xlink:type="simple"/><label>(57)</label></disp-formula>and<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e156" xlink:type="simple"/><label>(58)</label></disp-formula>respectively. Apparently paradoxically, if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e157" xlink:type="simple"/></inline-formula>, then we must have <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000539.e158" xlink:type="simple"/></inline-formula> for the terms inside the integrals to contribute non-trivially, and so these terms will be negative and therefore tend to <underline>reduce</underline> the averaged levels of monocytes and T-lymphocytes in the system. By (42) this will tend to increase the chemo-attractant concentration still further. In other words, once this chemo-attractant threshold is crossed the system tends (on average) to become yet more unstable.</p>
<p>There are of course other agents that damage monocytes or ECs that would cause the chemo-attractant level to increase, so that although for an individual this threshold might never be passed, in a large population there would be a continuous (and approximately linear) increase in cardiovascular risk with dose as shown in <xref ref-type="fig" rid="pcbi-1000539-g008">Figure 8</xref>. The same phenomenon would also occur at higher doses (e.g., at radiotherapeutic levels of dose), at a correspondingly higher level, although the relative magnitude of the perturbations would make the neglect of all but first order perturbations that we assumed in deriving (31)–(39) possibly invalid; there is abundant evidence of radiation-induced disease in groups exposed to certain forms of RT <xref ref-type="bibr" rid="pcbi.1000539-Adams1">[6]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-McGale1">[7]</xref>. Critical to our model, and indeed the understanding of atherosclerosis, is whether there really are such thresholds in chemo-attractant levels for the trans-intimal monocyte and T-lymphocyte flux. We assume the presence of such thresholds for the purposes of our stability analysis, as we have to if there is to be a stable solution, but it is possible nevertheless that these thresholds are zero, in which case, assuming the model is correct, the atherosclerotic process must be inherently unstable. As indicated above, if this is model is correct and is to be consistent with the observed cumulative cardiovascular disease mortality in developed populations <xref ref-type="bibr" rid="pcbi.1000539-World1">[28]</xref>, then the chemo-attractant (MCP-1) threshold must lie in the range [mean+0.25×population SD, mean+1.00× population SD] (the mean and population SD being as in Cannon <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Cannon1">[27]</xref>), in other words [1.0, 1.7]×10<sup>−14</sup> M ml<sup>−1</sup>.</p>
<p>We implicitly assume that atherosclerosis is mainly responsible for the observed excess risk of cardiovascular morbidity or mortality following fractionated low-dose irradiation of the heart and major arteries. This assumption is supported by experimental data in <italic>ApoE</italic><sup>−/−</sup> mice <xref ref-type="bibr" rid="pcbi.1000539-Hoving1">[35]</xref>. However, some human symptoms are due to (myocardial) ischaemia which could be caused by either macrovascular (atherosclerotic) or microvascular damage. At higher (radiotherapy) doses, both human and animal data suggest that both types of lesion occur <xref ref-type="bibr" rid="pcbi.1000539-Adams1">[6]</xref>. Although the generally high prevalence of atherosclerosis in humans suggests that this is the more probable cause of ischaemia following low-dose radiation, it is possible that microvascular disease also plays a role. It should be noted that we have been addressing mechanisms for induction of atherosclerosis following fractionated low-dose radiation to the large arteries (coronary, carotid etc). There is a large literature on fibrotic, pericardial, myocardial and other morbidity sequelae of high-dose irradiation of the heart and large arteries, both for humans and animals <xref ref-type="bibr" rid="pcbi.1000539-Adams1">[6]</xref>. The pro-inflammatory mechanisms for these are reasonably well understood, and quite different from those hypothesized here <xref ref-type="bibr" rid="pcbi.1000539-SchultzHector1">[36]</xref>. That the true mechanisms for low-dose effects are likely to be very different is also suggested by the pronounced fractionation effect seen for high-dose exposure in relation to heart failure in rats <xref ref-type="bibr" rid="pcbi.1000539-Lauk1">[37]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-SchultzHector2">[38]</xref>, in contrast to the somewhat lower risks observed in the Japanese atomic bomb survivors compared with occupationally exposed groups (<xref ref-type="table" rid="pcbi-1000539-t001">Table 1</xref>).</p>
<p>Indirect mechanisms for the action of radiation could also be postulated. At high doses it is clear that inflammatory markers are up-regulated <italic>in vitro</italic> and <italic>in vivo</italic>, although at lower doses if anything the evidence points to down-regulation of inflammation <xref ref-type="bibr" rid="pcbi.1000539-Little1">[16]</xref>. In terms of the model this could be mediated by an increase in radical flux, which could, via lipid peroxidation, lead to EC damage. This in turn would lead to an increase in the chemo-attractant signal. Radiation is known to cause long-term variation in certain T-cell subpopulations (CD4+) in the Japanese atomic bomb survivors <xref ref-type="bibr" rid="pcbi.1000539-Kusunoki1">[39]</xref>, and this mechanism could also be readily incorporated in the model. Long-term radiation-associated changes in cholesterol concentration have been observed in the Japanese atomic bomb survivors <xref ref-type="bibr" rid="pcbi.1000539-Wong1">[40]</xref>, presumably a result of some change in liver metabolism; these too could be easily incorporated in the model. It is of interest in this respect that there is a highly statistically significant trend with internal (plutonium α-particle) dose to the liver for ischaemic heart disease and cerebrovascular disease in the latest analysis of the Mayak worker data <xref ref-type="bibr" rid="pcbi.1000539-Azizova1">[14]</xref>. Set against that, there is little evidence of excess risk of circulatory disease risk, specifically cardiac disease in groups exposed to the diagnostic contrast medium Thorotrast, which delivered a substantial α-particle liver dose <xref ref-type="bibr" rid="pcbi.1000539-Travis1">[41]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-dosSantosSilva1">[42]</xref>.</p>
<p>An important consideration in estimating dose to the intima, and which may have a bearing on interpretation of certain epidemiological studies, is the role of oxygen diffusion. This has been modelled by Richardson <xref ref-type="bibr" rid="pcbi.1000539-Richardson1">[43]</xref>–<xref ref-type="bibr" rid="pcbi.1000539-Richardson3">[45]</xref>, who has highlighted the pronounced variations with oxygen concentration across the intima, which also varies with age as a result of modifications in arterial geometry <xref ref-type="bibr" rid="pcbi.1000539-Richardson2">[44]</xref>. It is well known that with decreasing oxygenation the effective dose reduces <xref ref-type="bibr" rid="pcbi.1000539-Richardson3">[45]</xref>, and this implies that biologically effective dose per unit exposure reduces by 8–12% from age 0.5 to 70 years, whether for high linear energy transfer (LET) (<sup>222</sup>Rn, <sup>218</sup>Po, <sup>214</sup>Po) or for low LET radiation <xref ref-type="bibr" rid="pcbi.1000539-Richardson3">[45]</xref>. This needs to be addressed in the dosimetry of any study; assuming that, as we argue above, intimal dose is of the most relevance to cardiovascular risk, not doing so would imply a modest negative bias in modifications of the radiation response by age at exposure.</p>
<p>Whilst the inflammatory process is recognized as an integral part of the atherosclerotic process <xref ref-type="bibr" rid="pcbi.1000539-Hansson1">[5]</xref> it does not explain the observation that the proliferation of vascular smooth muscle cells (VSMC) during atherosclerotic plaque development appears to be monoclonal <xref ref-type="bibr" rid="pcbi.1000539-Benditt1">[46]</xref>. Clonality suggests that plaque VSMCs must have undergone multiple rounds of division, and telomere loss studies argue that this is between 7–13 cumulative population doublings <xref ref-type="bibr" rid="pcbi.1000539-Matthews1">[47]</xref>. However, clonality itself is not synonymous with transformation of a single cell, and subsequent studies have shown that large patches in the normal vessel media are monoclonal <xref ref-type="bibr" rid="pcbi.1000539-Chung1">[48]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-Schwartz1">[49]</xref>. Thus, clonality is more likely to be explained by the presence of developmental clones in the normal vessel wall, rather than a mutation. Finally, in contrast to tumours, plaque VSMCs show poor proliferation, enhanced apoptosis, and early senescence <xref ref-type="bibr" rid="pcbi.1000539-Zhang1">[50]</xref>. These features would not confer a proliferative or survival advantage to plaque VSMCs. Furthermore, plaque VSMC proliferation is now seen to be beneficial in atherosclerosis <xref ref-type="bibr" rid="pcbi.1000539-Braganza1">[51]</xref>, so that the pathological consequences of a mutation promoting VSMC proliferation are unclear.</p>
<p>The limitations of the modelling performed here should be acknowledged. Even in the fuller model considered in <xref ref-type="supplementary-material" rid="pcbi.1000539.s001">Text S1</xref> section A there is much biology not included – simplifications have been made for analytical simplicity. Although not strictly a defect in the model, we assume in our motivating example that a certain (dose-dependent) fraction of the monocytes are killed instantaneously by radiation exposure. The magnitude of this fraction is based on data from a human bone-marrow colony-forming assay (for cells under hypoxic conditions) of Gordon <xref ref-type="bibr" rid="pcbi.1000539-Gordon1">[30]</xref> (<xref ref-type="supplementary-material" rid="pcbi.1000539.s004">Table S3</xref>), performed 9 days after irradiation. It is known that cells take a variable length of time to die after irradiation, as a result of the repair and mis-repair processes they are thought to be subject to <xref ref-type="bibr" rid="pcbi.1000539-Brenner1">[52]</xref>. As such, a possibly more realistic scenario would have assumed this total cell damage exponentially distributed over time rather than occurring instantaneously. However, it is unlikely that the variable delay in expression of monocyte mortality, which is likely to be 99.7% complete within three hours of irradiation <xref ref-type="bibr" rid="pcbi.1000539-Brenner1">[52]</xref>, will make much difference to the predictions of our model, concerned as it largely is with the consequences of fractionated radiation doses separated by days or more. It would not be too difficult to modify the equations (5), (6) and (8) to incorporate the simple repair-misrepair model outlined in Brenner <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Brenner1">[52]</xref>, although for the purposes of the present paper we regard this as an unnecessary elaboration.</p>
<p>That said, the simpler model proposed here we trust captures what is known about the main features of interaction of oxidized LDL and various other molecular species (MCP-1, G-CSF, bound lipid) with the various cellular species (monocytes, macrophages, T-lymphocytes) that are known to be of significance for induction of atherosclerosis. The mathematics underlying these reaction and diffusion processes is reasonably standard. What is interesting and novel about the present paper is that using only experimentally derived parameters (taken wherever possible from human data) (<xref ref-type="supplementary-material" rid="pcbi.1000539.s003">Tables S2</xref>, <xref ref-type="supplementary-material" rid="pcbi.1000539.s004">S3</xref>) we have reproduced what is observed in other experimental and epidemiologic data (<xref ref-type="fig" rid="pcbi-1000539-g007">Figures 7</xref>–<xref ref-type="fig" rid="pcbi-1000539-g008">8</xref>, <xref ref-type="table" rid="pcbi-1000539-t001">Table 1</xref>).</p>
<p>This proposed mechanism would in principle be experimentally testable. This would best be done <italic>in vitro</italic>, looking for changes in MCP-1 levels, or other potential chemo-attractants, in a co-culture system similar to that developed by Takaku <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Takaku1">[25]</xref>. This could be explored under a range of radiation exposure conditions (both localized and fractionated) and subsequent effects on, for example, adhesion properties could also be examined. <italic>In vivo</italic> experiments would be more complex (and expensive), but could also be performed, for example, using the <italic>ApoE</italic><sup>−/−</sup> knockout mouse model employed by Stewart <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1000539-Hoving1">[35]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-Stewart1">[53]</xref>. Even human data could be envisaged. In particular, if arterial tissue could be sampled from patients who have, a short time previously, received low-dose radiotherapy or high-dose diagnostic procedures (e.g., computerized tomography), together with suitable (age-matched) controls, one could determine whether intimal concentration of MCP-1 was significantly increased and the manner in which concentration changed with dose.</p>
<p>If the proposed mechanism were true, it also has substantive implications for radiological protection, which at present does not take cardiovascular disease into account <xref ref-type="bibr" rid="pcbi.1000539-International1">[54]</xref>. Analysis of the Japanese atomic bomb survivor data implies that non-cancer disease mortality, in particular cardiovascular mortality, contributes almost equally as cancer mortality to the radiogenic excess risk <xref ref-type="bibr" rid="pcbi.1000539-Preston1">[8]</xref>. The major uncertainty in assessing the low-dose risk of cardiovascular disease is the shape of the dose response relationship, which is very unclear in the Japanese data <xref ref-type="bibr" rid="pcbi.1000539-Preston1">[8]</xref>,<xref ref-type="bibr" rid="pcbi.1000539-Little3">[55]</xref>. The analysis of the present paper suggests that linear extrapolation would be generally appropriate for this endpoint.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pcbi.1000539.s001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.s001" xlink:type="simple"><label>Text S1</label><caption>
<p>Text S1 (sections A, B)</p>
<p>(0.46 MB DOC)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1000539.s002" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.s002" xlink:type="simple"><label>Table S1</label><caption>
<p>Candidate molecules for variables in the model.</p>
<p>(0.04 MB DOC)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1000539.s003" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.s003" xlink:type="simple"><label>Table S2</label><caption>
<p>Parameters and estimated values.</p>
<p>(0.35 MB DOC)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1000539.s004" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000539.s004" xlink:type="simple"><label>Table S3</label><caption>
<p>Values for perturbed species.</p>
<p>(0.07 MB DOC)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>The authors are grateful for the detailed and helpful comments of an associate editor and three referees. The Mayak worker analysis by Drs Azizova and Muirhead, which was cited in this paper, was conducted with support from the European Commission's Euratom Nuclear Fission and Radiation Protection Programme as part of the SOUL project; more details of this analysis can be found in separate papers by the study investigators.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pcbi.1000539-Murray1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Murray</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Lopez</surname><given-names>A</given-names></name>
</person-group>             <year>1997</year>             <article-title>Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study.</article-title>             <source>Lancet</source>             <volume>249</volume>             <fpage>1498</fpage>             <lpage>1505</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Ross1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ross</surname><given-names>R</given-names></name>
</person-group>             <year>1995</year>             <article-title>Cell biology of atherosclerosis.</article-title>             <source>Annual Rev Physiol</source>             <volume>57</volume>             <fpage>791</fpage>             <lpage>804</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Ross2"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ross</surname><given-names>R</given-names></name>
</person-group>             <year>1999</year>             <article-title>Atherosclerosis is an inflammatory disease.</article-title>             <source>Am Heart J</source>             <volume>138</volume>             <fpage>S419</fpage>             <lpage>420</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Lusis1"><label>4</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lusis</surname><given-names>A</given-names></name>
</person-group>             <year>2000</year>             <article-title>Atherosclerosis.</article-title>             <source>Nature</source>             <volume>407</volume>             <fpage>233</fpage>             <lpage>241</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Hansson1"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hansson</surname><given-names>GK</given-names></name>
</person-group>             <year>2005</year>             <article-title>Inflammation, atherosclerosis, and coronary artery disease.</article-title>             <source>N Engl J Med</source>             <volume>352</volume>             <fpage>1685</fpage>             <lpage>1695</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Adams1"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Adams</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Hardenbergh</surname><given-names>PH</given-names></name>
<name name-style="western"><surname>Constine</surname><given-names>LS</given-names></name>
<name name-style="western"><surname>Lipshultz</surname><given-names>SE</given-names></name>
</person-group>             <year>2003</year>             <article-title>Radiation-associated cardiovascular disease.</article-title>             <source>Critical Rev Oncol Hematol</source>             <volume>45</volume>             <fpage>55</fpage>             <lpage>75</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-McGale1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>McGale</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Darby</surname><given-names>SC</given-names></name>
</person-group>             <year>2005</year>             <article-title>Low doses of ionizing radiation and circulatory diseases: a systematic review of the published epidemiological evidence.</article-title>             <source>Radiat Res</source>             <volume>163</volume>             <fpage>247</fpage>             <lpage>257, 711</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Preston1"><label>8</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Preston</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Shimizu</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Pierce</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Suyama</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Mabuchi</surname><given-names>K</given-names></name>
</person-group>             <year>2003</year>             <article-title>Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950–1997.</article-title>             <source>Radiat Res</source>             <volume>160</volume>             <fpage>381</fpage>             <lpage>407</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Yamada1"><label>9</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Yamada</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Wong</surname><given-names>FL</given-names></name>
<name name-style="western"><surname>Fujiwara</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Akahoshi</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Suzuki</surname><given-names>G</given-names></name>
</person-group>             <year>2004</year>             <article-title>Noncancer disease incidence in atomic bomb survivors, 1958–1998.</article-title>             <source>Radiat Res</source>             <volume>161</volume>             <fpage>622</fpage>             <lpage>632</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Howe1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Howe</surname><given-names>GR</given-names></name>
<name name-style="western"><surname>Zablotska</surname><given-names>LB</given-names></name>
<name name-style="western"><surname>Fix</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Egel</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Buchanan</surname><given-names>J</given-names></name>
</person-group>             <year>2004</year>             <article-title>Analysis of the mortality experience amongst U.S. nuclear power industry workers after chronic low-dose exposure to ionizing radiation.</article-title>             <source>Radiat Res</source>             <volume>162</volume>             <fpage>517</fpage>             <lpage>526</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Ivanov1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ivanov</surname><given-names>VK</given-names></name>
<name name-style="western"><surname>Maksioutov</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Chekin</surname><given-names>SY</given-names></name>
<name name-style="western"><surname>Petrov</surname><given-names>AV</given-names></name>
<name name-style="western"><surname>Biryukov</surname><given-names>AP</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>The risk of radiation-induced cerebrovascular disease in Chernobyl emergency workers.</article-title>             <source>Health Phys</source>             <volume>90</volume>             <fpage>199</fpage>             <lpage>207</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-McGeoghegan1"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>McGeoghegan</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Binks</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Gillies</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Jones</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Whaley</surname><given-names>S</given-names></name>
</person-group>             <year>2008</year>             <article-title>The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946–2005.</article-title>             <source>Int J Epidemiol</source>             <volume>37</volume>             <fpage>506</fpage>             <lpage>518</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Muirhead1"><label>13</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Muirhead</surname><given-names>CR</given-names></name>
<name name-style="western"><surname>O'Hagan</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Haylock</surname><given-names>RGE</given-names></name>
<name name-style="western"><surname>Phillipson</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Willcock</surname><given-names>T</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers.</article-title>             <source>Br J Cancer</source>             <volume>100</volume>             <fpage>206</fpage>             <lpage>212</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Azizova1"><label>14</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Azizova</surname><given-names>TV</given-names></name>
<name name-style="western"><surname>Muirhead</surname><given-names>CR</given-names></name>
</person-group>             <year>2009</year>             <article-title>Epidemiological evidence for circulatory diseases – occupational exposure. EU Scientific Seminar 2008. “Emerging evidence for radiation induced circulatory diseases”. Proceedings of a scientific seminar held in Luxembourg on 25 November 2008.</article-title>             <source>Radiat Prot</source>             <volume>158</volume>             <fpage>33</fpage>             <lpage>46</lpage>             <comment>(downloadable from <ext-link ext-link-type="uri" xlink:href="http://ec.europa.eu/energy/nuclear/radiation_protection/doc/publication/158.pdf" xlink:type="simple">http://ec.europa.eu/energy/nuclear/radiation_protection/doc/publication/158.pdf</ext-link>)</comment>          </element-citation></ref>
<ref id="pcbi.1000539-Vrijheid1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Vrijheid</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Cardis</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Ashmore</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Auvinen</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Bae</surname><given-names>J-M</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Mortality from diseases other than cancer following low doses of ionizing radiation: results from the 15-Country Study of nuclear industry workers.</article-title>             <source>Int J Epidemiol</source>             <volume>36</volume>             <fpage>1126</fpage>             <lpage>1135</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Little1"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Little</surname><given-names>MP</given-names></name>
<name name-style="western"><surname>Tawn</surname><given-names>EJ</given-names></name>
<name name-style="western"><surname>Tzoulaki</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Wakeford</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Hildebrandt</surname><given-names>G</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms.</article-title>             <source>Radiat Res</source>             <volume>169</volume>             <fpage>99</fpage>             <lpage>109</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Little2"><label>17</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Little</surname><given-names>MP</given-names></name>
<name name-style="western"><surname>Tawn</surname><given-names>EJ</given-names></name>
<name name-style="western"><surname>Tzoulaki</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Wakeford</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Hildebrandt</surname><given-names>G</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms.</article-title>             <source>Radiat Environ Biophys</source>             <comment>re-submitted</comment>          </element-citation></ref>
<ref id="pcbi.1000539-Hayashi1"><label>18</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hayashi</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Kusunoki</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Hakoda</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Morishita</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kubo</surname><given-names>Y</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors.</article-title>             <source>Int J Radiat Biol</source>             <volume>79</volume>             <fpage>129</fpage>             <lpage>136</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Hayashi2"><label>19</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hayashi</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Morishita</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kubo</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kusunoki</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Hayashi</surname><given-names>I</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors.</article-title>             <source>Am J Med</source>             <volume>118</volume>             <fpage>83</fpage>             <lpage>86</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-McKay1"><label>20</label><element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>McKay</surname><given-names>C</given-names></name>
<name name-style="western"><surname>McKee</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Mottram</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Mulholland</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Wilson</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Towards a model of atherosclerosis.</article-title>             <comment>Strathclyde Mathematics Research Report (March 2005), No. 4</comment>          </element-citation></ref>
<ref id="pcbi.1000539-Cobbold1"><label>21</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cobbold</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Sherratt</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Maxwell</surname><given-names>S</given-names></name>
</person-group>             <year>2002</year>             <article-title>Lipoprotein oxidation and its significance for atherosclerosis: a mathematical approach.</article-title>             <source>Bull Math Biol</source>             <volume>64</volume>             <fpage>65</fpage>             <lpage>95</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Ibragimov1"><label>22</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ibragimov</surname><given-names>AI</given-names></name>
<name name-style="western"><surname>McNeal</surname><given-names>CJ</given-names></name>
<name name-style="western"><surname>Ritter</surname><given-names>LR</given-names></name>
<name name-style="western"><surname>Walton</surname><given-names>JR</given-names></name>
</person-group>             <year>2005</year>             <article-title>A mathematical model of atherogenesis as an inflammatory response.</article-title>             <source>Math Med Biol</source>             <volume>22</volume>             <fpage>305</fpage>             <lpage>333</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Keller1"><label>23</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Keller</surname><given-names>EF</given-names></name>
<name name-style="western"><surname>Segel</surname><given-names>LA</given-names></name>
</person-group>             <year>1971</year>             <article-title>Model for chemotaxis.</article-title>             <source>J Theoret Biol</source>             <volume>30</volume>             <fpage>225</fpage>             <lpage>234</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Keller2"><label>24</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Keller</surname><given-names>EF</given-names></name>
<name name-style="western"><surname>Segel</surname><given-names>LA</given-names></name>
</person-group>             <year>1971</year>             <article-title>Traveling bands of chemotactic bacteria: a theoretical analysis.</article-title>             <source>J Theoret Biol</source>             <volume>30</volume>             <fpage>235</fpage>             <lpage>248</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Takaku1"><label>25</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Takaku</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Wada</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Jinnouchi</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Takeya</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Takahashi</surname><given-names>K</given-names></name>
<etal/></person-group>             <year>1999</year>             <article-title>An in vitro coculture model of transmigrant monocytes and foam cell formation.</article-title>             <source>Arterioscler Thromb Vasc Biol</source>             <volume>19</volume>             <fpage>2330</fpage>             <lpage>2339</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Klouche1"><label>26</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Klouche</surname><given-names>M</given-names></name>
<name name-style="western"><surname>May</surname><given-names>AE</given-names></name>
<name name-style="western"><surname>Hemmes</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Messner</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kanse</surname><given-names>SM</given-names></name>
<etal/></person-group>             <year>1999</year>             <article-title>Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers.</article-title>             <source>Arterioscler Thromb Vasc Biol</source>             <volume>19</volume>             <fpage>784</fpage>             <lpage>793</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Cannon1"><label>27</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cannon</surname><given-names>JG</given-names></name>
<name name-style="western"><surname>Sabatier</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Marinik</surname><given-names>EL</given-names></name>
<name name-style="western"><surname>Schwark</surname><given-names>EH</given-names></name>
<name name-style="western"><surname>Haddow</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Femoral artery diameter and arteriogenic cytokines in healthy women.</article-title>             <source>Vascul Pharmacol</source>             <volume>50</volume>             <fpage>104</fpage>             <lpage>109</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-World1"><label>28</label><element-citation publication-type="other" xlink:type="simple">             <collab xlink:type="simple">World Health Organisation Statistical Information System (WHOSIS)</collab>             <year>2009</year>             <comment><ext-link ext-link-type="uri" xlink:href="http://www.who.int/whosis/en/" xlink:type="simple">http://www.who.int/whosis/en/</ext-link></comment>          </element-citation></ref>
<ref id="pcbi.1000539-United1"><label>29</label><element-citation publication-type="other" xlink:type="simple">             <collab xlink:type="simple">United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR)</collab>             <year>1993</year>             <source>Sources and effects of ionizing radiation. UNSCEAR 1993 report to the General Assembly, with scientific annexes</source>             <publisher-loc>New York</publisher-loc>             <publisher-name>United Nations</publisher-name>          </element-citation></ref>
<ref id="pcbi.1000539-Gordon1"><label>30</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gordon</surname><given-names>MY</given-names></name>
</person-group>             <year>1975</year>             <article-title>A comparison of the radiosensitivity and O.E.R. of human and mouse marrow progenitor cells cultured in agar in diffusion chambers.</article-title>             <source>Int J Radiat Biol</source>             <volume>28</volume>             <fpage>285</fpage>             <lpage>290</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Deschavanne1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Deschavanne</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Fertil</surname><given-names>B</given-names></name>
</person-group>             <year>1996</year>             <article-title>A review of human cell radiosensitivity <italic>in vitro</italic>.</article-title>             <source>International Journal of Radiat Oncol Biol Phys</source>             <volume>34</volume>             <fpage>251</fpage>             <lpage>266</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Cushing1"><label>32</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cushing</surname><given-names>SD</given-names></name>
<name name-style="western"><surname>Berliner</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Valente</surname><given-names>AJ</given-names></name>
<name name-style="western"><surname>Territo</surname><given-names>MC</given-names></name>
<name name-style="western"><surname>Navab</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>1990</year>             <article-title>Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.</article-title>             <source>Proc Natl Acad Sci USA</source>             <volume>87</volume>             <fpage>5134</fpage>             <lpage>5138</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Shi1"><label>33</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Shi</surname><given-names>Q</given-names></name>
<name name-style="western"><surname>Vandeberg</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Jett</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Rice</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Leland</surname><given-names>MM</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Arterial endothelial dysfunction in baboons fed a high-cholesterol, high-fat diet.</article-title>             <source>Am J Clin Nutr</source>             <volume>82</volume>             <fpage>751</fpage>             <lpage>759</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Kowalski1"><label>34</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kowalski</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Okopień</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Madej</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Zieliński</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Belowski</surname><given-names>D</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia.</article-title>             <source>Eur J Clin Pharmacol</source>             <volume>59</volume>             <fpage>189</fpage>             <lpage>193</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Hoving1"><label>35</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hoving</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Heeneman</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Gijbels</surname><given-names>MJJ</given-names></name>
<name name-style="western"><surname>te Poele</surname><given-names>JAM</given-names></name>
<name name-style="western"><surname>Russell</surname><given-names>NS</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in ApoE<sup>−/−</sup> mice.</article-title>             <source>Int J Radiat Oncol Biol Phys</source>             <volume>71</volume>             <fpage>848</fpage>             <lpage>857</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-SchultzHector1"><label>36</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Schultz-Hector</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Trott</surname><given-names>K-R</given-names></name>
</person-group>             <year>2007</year>             <article-title>Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?</article-title>             <source>Int J Radiat Oncol Biol Phys</source>             <volume>67</volume>             <fpage>10</fpage>             <lpage>18</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Lauk1"><label>37</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lauk</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Rüth</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Trott</surname><given-names>KR</given-names></name>
</person-group>             <year>1987</year>             <article-title>The effects of dose-fractionation on radiation-induced heart disease in rats.</article-title>             <source>Radiother Oncol</source>             <volume>8</volume>             <fpage>363</fpage>             <lpage>367</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-SchultzHector2"><label>38</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Schultz-Hector</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sund</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Thames</surname><given-names>HD</given-names></name>
</person-group>             <year>1992</year>             <article-title>Fractionation response and repair kinetics of radiation-induced heart failure in the rat.</article-title>             <source>Radiother Oncol</source>             <volume>23</volume>             <fpage>33</fpage>             <lpage>40</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Kusunoki1"><label>39</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kusunoki</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kyoizumi</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Hirai</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Nakashima</surname><given-names>E</given-names></name>
<etal/></person-group>             <year>1998</year>             <article-title>Flow cytometry measurements of subsets of T, B and NK cells in peripheral blood lymphocytes of atomic bomb survivors.</article-title>             <source>Radiat Res</source>             <volume>150</volume>             <fpage>227</fpage>             <lpage>236</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Wong1"><label>40</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wong</surname><given-names>FL</given-names></name>
<name name-style="western"><surname>Yamada</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Sasaki</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Kodama</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Hosoda</surname><given-names>Y</given-names></name>
</person-group>             <year>1999</year>             <article-title>Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors: 1958–1986.</article-title>             <source>Radiat Res</source>             <volume>151</volume>             <fpage>736</fpage>             <lpage>746</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Travis1"><label>41</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Travis</surname><given-names>LB</given-names></name>
<name name-style="western"><surname>Land</surname><given-names>CE</given-names></name>
<name name-style="western"><surname>Andersson</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Nyberg</surname><given-names>U</given-names></name>
<name name-style="western"><surname>Goldman</surname><given-names>MB</given-names></name>
<etal/></person-group>             <year>2001</year>             <article-title>Mortality after cerebral angiography with or without radioactive Thorotrast: an international cohort of 3,143 two-year survivors.</article-title>             <source>Radiat Res</source>             <volume>156</volume>             <fpage>136</fpage>             <lpage>150</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-dosSantosSilva1"><label>42</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>dos Santos Silva</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Malveiro</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Jones</surname><given-names>ME</given-names></name>
<name name-style="western"><surname>Swerdlow</surname><given-names>AJ</given-names></name>
</person-group>             <year>2003</year>             <article-title>Mortality after radiological investigation with radioactive Thorotrast: a follow-up study of up to fifty years in Portugal.</article-title>             <source>Radiat Res</source>             <volume>159</volume>             <fpage>521</fpage>             <lpage>534</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Richardson1"><label>43</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Richardson</surname><given-names>RB</given-names></name>
</person-group>             <year>2008</year>             <article-title>Age-dependent changes in oxygen tension, radiation dose and sensitivity within normal and diseased coronary arteries - Part A: Dose from radon and thoron.</article-title>             <source>Int J Radiat Biol</source>             <volume>84</volume>             <fpage>838</fpage>             <lpage>848</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Richardson2"><label>44</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Richardson</surname><given-names>RB</given-names></name>
</person-group>             <year>2008</year>             <article-title>Age-dependent changes in oxygen tension, radiation dose and sensitivity within normal and diseased coronary arteries - Part B: Modeling oxygen diffusion into vessel walls.</article-title>             <source>Int J Radiat Biol</source>             <volume>84</volume>             <fpage>849</fpage>             <lpage>857</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Richardson3"><label>45</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Richardson</surname><given-names>RB</given-names></name>
</person-group>             <year>2008</year>             <article-title>Age-dependent changes in oxygen tension, radiation dose and sensitivity within normal and diseased coronary arteries - Part C: Oxygen effect and its implications on high- and low-LET dose.</article-title>             <source>Int J Radiat Biol</source>             <volume>84</volume>             <fpage>858</fpage>             <lpage>865</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Benditt1"><label>46</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Benditt</surname><given-names>EP</given-names></name>
<name name-style="western"><surname>Benditt</surname><given-names>JM</given-names></name>
</person-group>             <year>1973</year>             <article-title>Evidence for a monoclonal origin of human atherosclerotic plaques.</article-title>             <source>Proc Natl Acad Sci USA</source>             <volume>70</volume>             <fpage>1753</fpage>             <lpage>1756</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Matthews1"><label>47</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Matthews</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Gorenne</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Scott</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Figg</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Kirkpatrick</surname><given-names>P</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress.</article-title>             <source>Circ Res</source>             <volume>99</volume>             <fpage>156</fpage>             <lpage>164</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Chung1"><label>48</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Chung</surname><given-names>I-M</given-names></name>
<name name-style="western"><surname>Schwartz</surname><given-names>SM</given-names></name>
<name name-style="western"><surname>Murry</surname><given-names>CE</given-names></name>
</person-group>             <year>1998</year>             <article-title>Clonal architecture of normal and atherosclerotic aorta - Implications for atherogenesis and vascular development.</article-title>             <source>Am J Pathol</source>             <volume>152</volume>             <fpage>913</fpage>             <lpage>923</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Schwartz1"><label>49</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Schwartz</surname><given-names>SM</given-names></name>
<name name-style="western"><surname>Murry</surname><given-names>CE</given-names></name>
</person-group>             <year>1998</year>             <article-title>Proliferation and the monoclonal origins of atherosclerotic lesions.</article-title>             <source>Annu Rev Med</source>             <volume>49</volume>             <fpage>437</fpage>             <lpage>460</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Zhang1"><label>50</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zhang</surname><given-names>QJ</given-names></name>
<name name-style="western"><surname>Goddard</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Shanahan</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Shapiro</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Bennett</surname><given-names>M</given-names></name>
</person-group>             <year>2002</year>             <article-title>Differential gene expression in vascular smooth muscle cells in primary atherosclerosis and in stent stenosis in humans.</article-title>             <source>Arterioscler Thromb Vasc Biol</source>             <volume>22</volume>             <fpage>2030</fpage>             <lpage>2036</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Braganza1"><label>51</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Braganza</surname><given-names>DM</given-names></name>
<name name-style="western"><surname>Bennett</surname><given-names>MR</given-names></name>
</person-group>             <year>2001</year>             <article-title>New insights into atherosclerotic plaque rupture.</article-title>             <source>Postgrad Med J</source>             <volume>77</volume>             <fpage>94</fpage>             <lpage>98</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Brenner1"><label>52</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Brenner</surname><given-names>DJ</given-names></name>
<name name-style="western"><surname>Hlatky</surname><given-names>LR</given-names></name>
<name name-style="western"><surname>Hahnfeldt</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Sachs</surname><given-names>RK</given-names></name>
</person-group>             <year>1998</year>             <article-title>The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.</article-title>             <source>Radiat Res</source>             <volume>150</volume>             <fpage>83</fpage>             <lpage>91</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Stewart1"><label>53</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Stewart</surname><given-names>FA</given-names></name>
<name name-style="western"><surname>Heeneman</surname><given-names>S</given-names></name>
<name name-style="western"><surname>te Poele</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Kruse</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Russell</surname><given-names>NS</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE<sup>−/−</sup> mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage.</article-title>             <source>Am J Pathol</source>             <volume>168</volume>             <fpage>649</fpage>             <lpage>658</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-International1"><label>54</label><element-citation publication-type="journal" xlink:type="simple">             <collab xlink:type="simple">International Commission on Radiological Protection</collab>             <article-title>The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103.</article-title>             <source>Annals ICRP</source>             <volume>2007; 37 (2–4)</volume>             <fpage>i</fpage>             <lpage>ii+1–332</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Little3"><label>55</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Little</surname><given-names>MP</given-names></name>
</person-group>             <year>2004</year>             <article-title>Threshold and other departures from linear-quadratic curvature in the non-cancer mortality dose-response curve in the Japanese atomic bomb survivors.</article-title>             <source>Radiat Environ Biophys</source>             <volume>43</volume>             <fpage>67</fpage>             <lpage>75</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Kreuzer1"><label>56</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kreuzer</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kreisheimer</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kandel</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Schnelzer</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Tschense</surname><given-names>A</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Mortality from cardiovascular diseases in the German uranium miners cohort study, 1946–1998.</article-title>             <source>Radiat Environ Biophys</source>             <volume>45</volume>             <fpage>159</fpage>             <lpage>166</lpage>          </element-citation></ref>
<ref id="pcbi.1000539-Richardson4"><label>57</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Richardson</surname><given-names>DB</given-names></name>
<name name-style="western"><surname>Wing</surname><given-names>S</given-names></name>
</person-group>             <year>1999</year>             <article-title>Radiation and mortality of workers at Oak Ridge National Laboratory: positive associations for doses received at older ages.</article-title>             <source>Environ Health Perspect</source>             <volume>107</volume>             <fpage>649</fpage>             <lpage>656</lpage>          </element-citation></ref>
</ref-list>

</back>
</article>